Signal generation and clarification: Use of case-control data

Pharmacoepidemiology and Drug Safety

Volumn 10, Issue 3, 2001, Pages 197-203

  Kaufman, David W ^a   Rosenberg, Lynn ^a   Mitchell, Allen A ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Epidemiology; Hypothesis generation; Screening

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; BENDECTIN; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; DIAZEPAM; ESTROGEN; GENERIC DRUG; HORMONE DERIVATIVE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PROSTAGLANDIN INHIBITOR; PSEUDOEPHEDRINE; RETINOL; SPERMICIDAL AGENT;

ADULT; ARTICLE; BIRTH DEFECT; CASE CONTROL STUDY; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC VALUE; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH SERVICE; HUMAN; INFANT; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OUTCOMES RESEARCH; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; SCREENING; SIDE EFFECT; SIGNAL DETECTION; TOBACCO;

CASE-CONTROL STUDIES; HUMANS; PRODUCT SURVEILLANCE, POSTMARKETING; RISK ASSESSMENT;

EID: 0034897965     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.571     Document Type: Article

References (38)

1. Case-control Surveillance
2. Case-control surveillance of serious illnesses attributable to ambulatory drug use
3. Birth defects related to Bendectin use in pregnancy: 1. Oral clefts and cardiac defects
4. Slone Epidemiology Unit Birth Defects Study
5. Congenital abnormalities in the offspring of women who used oral contraceptives around the time of conception
6. Comparing the prevalence of smoking in pregnant and non-pregnant women
7. Moderate caffeine use and the risk of spontaneous abortion and intrauterine growth retardation
8. Statistical aspects of the analysis of data from retrospective studies of disease
9. Breast cancer and alcoholic-beverage consumption
10. Alcohol consumption and risk of breast cancer: A review of the evidence
11. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women
12. First trimester maternal medication use in relation to gastroschisis
13. Maternal medications and environmental exposures as risk factors for gastroschisis
14. Noncontraceptive estrogen use and epithelial ovarian cancer
15. Thiazides and acute cholecystitis
16. Evidence of increased risk of Crohn's disease in oral contraceptive users
17. Oral contraceptive use and liver cancer
18. Gestational trophoblastic disease and use of oral-contraceptives
19. Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium
20. Case-control study of oral contraceptive use and risk of breast cancer
21. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer
22. Decreased risk of endometrial cancer among oral contraceptive users
23. A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large bowel cancer
24. Maternal alcohol use in relation to selected birth defects
25. Maternal vitamin A supplementation in relation to selected birth defects
26. Periconceptional folic acid exposure and risk of occurent neural tube defects
27. Diazepam and the risk of breast cancer
28. Relation of benzodiazepine use to the risk of selected cancers: Breast, large bowel, malignant melanoma, lung, endometrium, ovary, non-Hodgkins lymphoma, testis, Hodgkin's disease, thyroid and liver
29. Use of thyroid supplements in relation to the risk of breast cancer
30. Risk of breast cancer in relation to the use of rauwolfia alkaloids
31. Hydralazine and breast cancer
32. Hydralazine use in relation to cancers of the lung, colon, and rectum
33. Birth defects in relation to Bendectin use in pregnancy. II. Pyloric stenosis
34. Selected birth defects in relation to caffeine-containing beverages
35. Lack of relation of oral clefts to diazepam use during pregnancy
36. Maternal exposure to spermicides in relation to certain birth defects
37. The relation of first trimester aspirin use during the first trimester of pregnancy to congenital cardiac defects
38. Ovulation induction and risk of neural tube defects